Prevalence and prognostic significance of left ventricular dysfunction in patients presenting acutely with Atrial fibrillation

Clinical Medicine Insights: Cardiology

Volumn 4, Issue , 2010, Pages 23-29

  Lin, Chin ^a   Edwards, Colin ^a   Armstrong, Guy P ^a   Scott, Anthony ^a   Patel, Hitesh ^a   Hart, Hamish ^a   Christiansen, Jonathan P ^a  

^a NORTH SHORE HOSPITAL   (New Zealand)

Author keywords

Atrial fibrillation; Cardiomyopathy; Prevalence; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; WARFARIN;

ACUTE DISEASE; AGED; ANAMNESIS; ARTICLE; CARDIOMYOPATHY; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PREVALENCE; PROGNOSIS; TACHYCARDIA;

EID: 77952538799     PISSN: None     EISSN: 11795468     Source Type: Journal    
DOI: 10.4137/cmc.s4106     Document Type: Article

References (12)

1. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994;271:840-4.
2. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence age distribution and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995;155:469-73.
3. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22(suppl A):6A-13A.
4. Cha Y, Redfield M, Shen W, et al. Atrial Fibrillation and Ventricular Dysfunction-A Vicious Electromechanical Cycle. Circulation. 2004;109: 2839-43.
5. Shinbane J, Wood M, Jensen N, et al. Tachycardia-induced Cardiomyopathy: A review of Animal Models and Clinical Studies. J Am Coll Cardiol. 1997;29:709-15.
6. Morrison TB, Bunch TJ, Gersh BJ. Pathophysiology of concomitant atrial fibrillation and heart failure: implications for management. Nature Clin prac. 2008;6(1):46-56.
7. Grogan M, Smith HC, Gersh BJ. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;68:1570-3.
8. Kieny JR, Sacrez A, Facello A, Arbogast R, Bareiss P, Roul G, et al. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. Eur Heart J. 1992;13:1290-5.
9. Ozcan C, Jahangir A, Friedman PA, et al. Significant effects of atrioventricular node ablation and pacemaker implantation on left ventricular function and long-term survival in patients with atrial fibrillation and left ventricular dysfunction. Am J Cardiol. 2003;92:33-7.
10. Phillips E, Levine S. Auricular fibrillation without other evidence of heart disease: a cause of reversible heart failure. Am J Med. 1949;7:478-89.
11. Hsu L-F, Jais P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med. 2004;351:2373-83.
12. Wang T, Larson M, Levy D, et al. Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence of Mortality-The Framingham Heart Study. Circulation. 2003;107:2920-5.